Nom du produit:(R)-1-Boc-3-Aminopiperidine
IUPAC Name:tert-butyl (3R)-3-aminopiperidine-1-carboxylate
- CAS:188111-79-7
- Formule moléculaire:C10H20N2O2
- Pureté:97%
- Numéro de catalogue:CM101966
- Poids moléculaire:200.28
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:188111-79-7
- Formule moléculaire:C10H20N2O2
- Point de fusion:-
- Code SMILES:N[C@H]1CN(C(OC(C)(C)C)=O)CCC1
- Densité:1.041g/cm3
- Numéro de catalogue:CM101966
- Poids moléculaire:200.28
- Point d'ébullition:277.3°C at 760 mmHg
- N° Mdl:MFCD03094717
- Stockage:
Category Infos
- Piperidines
- Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
- Piperidine,Piperidine Price
- if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.
Column Infos
- NX-5948
- Nurix announced the presentation of the first findings of clinical responses in the brain for NX-5948. NX-5948 is an investigational, orally bioavailable, brain penetrant, small molecule degrader of BTK. NX-5948 is currently being evaluated in a Phase 1 clinical trial in patients with relapsed or refractory B cell malignancies.
- Tolebrutinib
- Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis(nrSPMS).
Tolebrutinib is an investigational, oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase (BTK) inhibitor that achieves CSF concentrations predicted to modulate B lymphocytes and disease-associated microglia.